Schuck S

References (4)

Title : Use of drug treatments for Alzheimer's disease in France: a study on a national level based on the National Alzheimer's Data Bank (Banque Nationale Alzheimer) - Tifratene_2012_Pharmacoepidemiol.Drug.Saf_21_1005
Author(s) : Tifratene K , Duff FL , Pradier C , Quetel J , Lafay P , Schuck S , Benzenine E , Quantin C , Robert P
Ref : Pharmacoepidemiol Drug Safety , 21 :1005 , 2012
Abstract : Tifratene_2012_Pharmacoepidemiol.Drug.Saf_21_1005
ESTHER : Tifratene_2012_Pharmacoepidemiol.Drug.Saf_21_1005
PubMedSearch : Tifratene_2012_Pharmacoepidemiol.Drug.Saf_21_1005
PubMedID: 22718684

Title : [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice] - Robert_2003_Encephale_29_266
Author(s) : Robert PH , Schuck S , Dubois B , Lepine JP , Gallarda T , Olie JP , Goni S , Troy S
Ref : Encephale , 29 :266 , 2003
Abstract : Robert_2003_Encephale_29_266
ESTHER : Robert_2003_Encephale_29_266
PubMedSearch : Robert_2003_Encephale_29_266
PubMedID: 12876552

Title : [Adverse effects and drugs for Alzheimer's disease] - Schuck_1999_Therapie_54_237
Author(s) : Schuck S , Bentue-Ferrer D , Beaufils C , Polard E , Belliard S , Allain H
Ref : Therapie , 54 :237 , 1999
Abstract : Schuck_1999_Therapie_54_237
ESTHER : Schuck_1999_Therapie_54_237
PubMedSearch : Schuck_1999_Therapie_54_237
PubMedID: 10394260

Title : Aminotransferase levels and silymarin in de novo tacrine-treated patients with Alzheimer's disease - Allain_1999_Dement.Geriatr.Cogn.Disord_10_181
Author(s) : Allain H , Schuck S , Lebreton S , Strenge-Hesse A , Braun W , Gandon JM , Brissot P
Ref : Dementia & Geriatric Cognitive Disorders , 10 :181 , 1999
Abstract : Allain_1999_Dement.Geriatr.Cogn.Disord_10_181
ESTHER : Allain_1999_Dement.Geriatr.Cogn.Disord_10_181
PubMedSearch : Allain_1999_Dement.Geriatr.Cogn.Disord_10_181
PubMedID: 10325444